Implication de la sortiline dans la résistance des cellules cancéreuses au 5-Fluorouracile. Cas du cancer colorectal

Abstract : Worldwide, colorectal cancer (CRC) is the second leading cause of cancer-related deaths. Colorectal adenocarcinomas are divided into low and high grades. More advanced tumor grade is associated with poorer global survival following 5-fluorouracil (5-FU)-based systemic chemotherapy. Even when 5-FU is used as the first-line molecule, responsiveness is only 20–30%, and drug resistance contributes to both poor patient prognosis and relapses, emphasizing the need to identify biomarkers involved in this process. In this study, we focused on sortilin, a multifunctional protein among VPS10P domain-related receptors with sorLA and sorCS1-3, that acts as a receptor and co-receptor as well as a regulator of intra- and extracellular protein sorting and trafficking. We obtained evidence that sortilin, but not sorLA, is a biomarker of CRC aggressiveness associated with poor clinical outcomes. In vivo and in vitro, in both 5-FU–resistant CRC cell lines and primary cultures, only sortilin was overexpressed at both protein and mRNA levels, indicating that it could serve as a biomarker of 5-FU resistance regardless of tumor grade and mutational status. Sortilin overexpression is especially localized in Golgi apparatus of 5-FU resistant cells and seems to be transcriptionally regulated through ATF-3 downregulation. Genetic (shRNA) and pharmacological (CADA) inhibition of sortilin potentiated 5-FU–induced cytotoxicity, resulting in a significant increase in cancer cell eradication, implying that sortilin is also actively involved in 5-FU resistance. Moreover, sorLA expression is unchanged upon sortilin inhibition. Our findings indicate that sortilin is a promising biomarker of 5-FU resistance in CRC, as well as a potential therapeutic target for overcoming 5-FU resistance.
Document type :
Complete list of metadatas

Cited literature [886 references]  Display  Hide  Download
Contributor : Abes Star <>
Submitted on : Tuesday, September 10, 2019 - 1:32:45 PM
Last modification on : Wednesday, September 11, 2019 - 1:22:14 AM


Version validated by the jury (STAR)


  • HAL Id : tel-02282994, version 1



Sabrina Blondy. Implication de la sortiline dans la résistance des cellules cancéreuses au 5-Fluorouracile. Cas du cancer colorectal. Médecine humaine et pathologie. Université de Limoges, 2019. Français. ⟨NNT : 2019LIMO0020⟩. ⟨tel-02282994⟩



Record views


Files downloads